Postremission gemtuzumab ozogamicin for elderly patients with acute myelogenous leukemia with favorable characteristics and comorbid conditions.

Source:http://linkedlifedata.com/resource/pubmed/id/20978876

Download in:

View as

General Info

PMID
20978876